RRoche Read More Roche H1 Results: 6% Growth, Exchange-Rate Adjusted2026-07-23 Roche (OTCQX:RHHBY) reported first-half 2026 Group sales of CHF 30.4 billion, up 6% at constant…
NNovartis Read More Novartis Faces Sales and Profit Decline Amid Entresto Generic Competition, ETPharma2026-04-28 London: Swiss drugmaker Novartis reported first-quarter core operating profit and sales below market expectations on Tuesday, as generic…